|
Daratumumab Injection Clinical Trials
4 actively recruiting trials across 2 locations
Also known as: Darzalex
Pipeline
Phase 2: 1Phase 3: 1Phase 1/2: 2
Top Sponsors
- University of Maryland, Baltimore1
- Tata Memorial Centre1
- Stichting Hemato-Oncologie voor Volwassenen Nederland1
- Rajshekhar Chakraborty, MD1
Indications
- Cancer4
- T Acute Lymphoblastic Leukemia1
- Plasma Cell Disorder1
- AL Amyloidosis1
- Multiple Myeloma1
Other2 trials
Baltimore, Maryland1 trial
Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders
University of Maryland Greenebaum Comprehensive Cancer Center
Phase 1/2
Boston, Massachusetts1 trial
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Boston Medical Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.